ARCHIVES

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

This article is from The Cancer Letter archive.

Vol. 31 No. 01 | January 7, 2005

Download PDF Visit The Full Archive

Related Articles

NIH Consensus Panel Calls for Large Randomized Trials of Hepatitis B Therapies.

October 31, 2008

In Brief: Roper To Resign From CDC; Clinton Nominates Phillip Lee For Asst. Secretary For Health

March 19, 1993

FDA Publishes Two Guidances for Lab-Developed Tests

October 3, 2014

Adamson, Henney Chair Silicone Task Force

April 25, 1992

Gleevec To Prevent Recurrence Of Gastrointestinal Cancer

December 26, 2008

Competition Developing For Three New Regional Cooperative Group Awards; RFA Within Two Months

December 12, 1980